Analystreport

Kezar Life Sciences Inc (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at William Blair.

Kezar Life Sciences, Inc.  (KZR) 
Last kezar life sciences, inc. earnings: 8/7 04:05 pm Check Earnings Report